Skip to content

Disc Medicine IRON Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Beam Therapeutics logo
Beam TherapeuticsBEAM
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's software and technology licenses, net?
Disc Medicine (IRON) reported software and technology licenses, net of $721K in Q1 2026.
How has Disc Medicine's software and technology licenses, net changed year-over-year?
Disc Medicine's software and technology licenses, net decreased by 14.1% year-over-year, from $839K to $721K.
What is the long-term trend for Disc Medicine's software and technology licenses, net?
Over 4 years (2021 to 2025), Disc Medicine's software and technology licenses, net has grown at a 41.7% compound annual growth rate (CAGR), from $180K to $726K.